Oncogenic ras Causes Resistance to the Growth Inhibitor Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) in Breast Cancer Cells
Open Access
- 1 June 1999
- journal article
- Published by Elsevier
- Vol. 274 (23) , 16407-16411
- https://doi.org/10.1074/jbc.274.23.16407
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Development of Resistance to Insulin-like Growth Factor Binding Protein-3 in Transfected T47D Breast Cancer CellsBiochemical and Biophysical Research Communications, 1998
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Estradiol and Antiestrogens Regulate a Growth Inhibitory Insulin-like Growth Factor Binding Protein 3 Autocrine Loop in Human Breast Cancer CellsJournal of Biological Chemistry, 1996
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoJournal of Biological Chemistry, 1995
- Induction of the growth inhibitor IGF-binding protein 3 by p53Nature, 1995
- Aberrant function of the Ras signal transduction pathway in human breast cancerBreast Cancer Research and Treatment, 1995
- Insulin-like Growth Factor Binding Protein 3 (IGF-BP3) Inhibits Estrogen-Stimulated Breast Cancer Cell ProliferationBiochemical and Biophysical Research Communications, 1994
- Insulin-like growth factor-I (IGF-I) and transforming growth factor- beta 1 release IGF-binding protein-3 from human fibroblasts by different mechanismsEndocrinology, 1992
- Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanismEndocrinology, 1992
- Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblastsBiochemical and Biophysical Research Communications, 1988